Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

3.20
Delayed Data
As of Jun 28
 +0.19 / +6.31%
Today’s Change
2.60
Today|||52-Week Range
28.60
-28.57%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close3.01
Today’s open3.12
Day’s range3.00 - 3.22
Volume121,289
Average volume (3 months)242,546
Market cap$29.9M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+35.21%
Earnings growth (this year)+83.21%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+4,854.55%
P/E ratio--
Price/Sales28.00
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...0.000.00%
IMUCImmunoCellular Thera...+0.02+8.45%
OPGNOpGen Inc+0.16+11.43%
PBMDPrima BioMed Ltd+0.01+1.33%
Data as of 4:01pm ET, 06/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$545.0K
Annual profit (last year)-$50.1M
Net profit margin-9,216.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Dodd
Chief Accounting Officer &
Vice President-Finance
Geneviève Lemaire
Corporate headquarters
Québec, Qubec

Forecasts

Partner Offers

Search for Jobs